DR. ANTONY CHUNTING HOU M.D. NPI 1114926367

NPI Information

  • NPI: 1114926367
  • Provider Name: DR. ANTONY CHUNTING HOU, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1238 E ARROW HWY
    UPLAND, CA
    ZIP 91786
  • Phone: (909) 982-0099

Map and Directions

Get Directions

NPI Details

DR. Antony Chunting Hou, M.D. is a rheumatology internal medicine in Upland, CA with 21 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Antony Chunting Hou, M.D. NPI is 1114926367. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1238 E ARROW HWY
UPLAND, CA
ZIP 91786-951
Phone: (909) 982-0099
Fax: (909) 931-0402

The NPI 1114926367 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Methotrexate sodium, 5 mg (HCPCS:J9250)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Uric acid level, blood (HCPCS:84550)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Immune complex measurement (HCPCS:86332)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Injection into tendon or ligament (HCPCS:20550)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Liver function blood test panel (HCPCS:80076)
  • Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Aspiration and/or injection of fluid from medium joint using ultrasound guidance (HCPCS:20606)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
  • Screening test for autoimmune disorder (HCPCS:86038)

The enumeration date for this NPI number is 7/19/2005 and was last updated on 1/18/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialistA73744CALIFORNIANo
2207RR0500XInternal MedicineRheumatologyA73744CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1GR0091870MEDICAIDCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.